Non-Functional Paraganglioma of the Urinary Bladder Treated by Transurethral Resection: Report of Two Cases

Paraganglioma of the urinary bladder is a rare tumour derived from chromaffin tissue of the sympathetic nervous system. Paraganglioma of the urinary bladder especially the non-functional type is often misdiagnosed as urothelial cancer.

Two female patients aged 32 years and 45 years presented with painless haematuria without any symptoms of catecholamine excess. Radiological investigations revealed urinary bladder tumour. The tumour was removed by transurethral resection in both the patients. Histopathological diagnosis was paraganglioma, which was confirmed by immunohistochemistry. Complete resection of tumour by transurethral approach is curative in paraganglioma of the urinary bladder. We hereby, also discuss the salient features of nonfunctional paraganglioma of the urinary bladder.

Journal of clinical and diagnostic research : JCDR. 2016 Feb 01 [Epub]

Richa Katiyar, Saloni Dwivedi, Sameer Trivedi, Shashikant C U Patne, Uday Shankar Dwivedi

Service Senior Resident, Department of Pathology, Institute of Medical Sciences, Banaras Hindu University , Varanasi, (U.P.), India ., Junior Resident, Department of Pathology, Institute of Medical Sciences, Banaras Hindu University , Varanasi, (U.P.), India ., Associate Professor, Department of Urology, Institute of Medical Sciences, Banaras Hindu University , Varanasi, (U.P.), India ., Assistant Professor, Department of Pathology, Institute of Medical Sciences, Banaras Hindu University , Varanasi, (U.P.), India., Professor and Head, Department of Urology, Institute of Medical Sciences, Banaras Hindu University , Varanasi, (U.P.), India .

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe